References
- Almeida AJ, Runge S, Müller RH. Peptide-loaded solid lipid nanoparticles (SLN): Influence of production parameters. International Journal of Pharmaceutics 1997; 149: 255–265
- Bargoni A, Cavalli R, Caputo O, Fundarò A, Gasco MR, Zara GP. Solid lipid nanoparticles in lymph and plasma after duodenal administration to rats. Pharmaceutical Research 1998; 15: 745–750
- Brange J, Havelund P, Hougaard P. Chemical stability of insulin.1. Hydrolytic degradation during storage of pharmaceutical preparations. Pharmaceutical Research 1992; 9: 715–727
- Bunjes H, Siekmann B, Westesen K. Emulsion of supercooled melts, a novel drug delivery system. Submicron emulsions in drug targeting and delivery, S Benita. Harwood Academic Publisher, AmsterdamThe Netherlands 1998; 175–205
- Domb AJ. Lipospheres for controlled delivery of substances. US patent 5188837, 1993
- Gasco MR. Method for producing solid lipid microspheres having a narrow size distribution. US patent, USS 188837, 1993
- Jahnke S. The theory of high pressure homogenisation. Emulsions and nanosuspensions for the formulation of poorly soluble drugs, RH Müller, S Benita, B Bohm. Medpharm Scientific Publishers, Stuttgart 1998; 177–200
- Mehnert W, Mäder K. Solid lipid nanoparticles. Production, characterization and applications. Advanced Drug Delivery Reviews 2001; 47: 165–196
- Müller RH, Lucks JS. Arzneistoffträger aus festen Lipidteilchen, Feste Lipidnanosphären (SLN). European patent 0605497, 1996
- Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery—A review of the state of the art. European Journal of Pharmaceutics and Biopharmaceutics 2000; 50: 161–177
- Müller RH, Radtke M, Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drugs. International Journal of Pharmaceutics 2002; 242: 121–128
- Muranishi S. Drug targeting towards the lymphatics. Advances in drug research, B Testa. Academic Press, London 1991; 21: 1–38
- Muranishi S, Fujita T, Murakami M, Yamamoto A. Potential for lymphatic targeting of peptides. Journal of Controlled Release 1997; 46: 157–164
- Reithmeier H, Hermann J, Gopferich A. Lipid microparticles as a parenteral controlled devices for peptides. Journal of Controlled Release 2001; 73: 133–143
- Sah H, Smith MS, Chern RT. A novel method of preparing PLGA microcapsules utilizing methylethyl ketone. Pharmaceutical Research 2000; 13: 360–367
- Siekmann B, Westesen K. Investigation on solid lipid nanoparticles prepared by precipitation in O/W emulsion. European Journal of Pharmaceutics and Biopharmaceutics 1996; 43: 104–109
- Silva CM, Ribeiro AJ, Figuereido IV, Rocha Goncalves A, Veiga F. Alginate microspheres prepared by internal gelation: Development and effect on insulin stability. International Journal of Pharmaceutics 2006; 311: 1–10
- Sjöstrom B, Bergenstahl B. Preparation of submicron drug particles in lecithin-stabilized o/w emulsions I. Model studies of the precipitation of cholesteryl acetate. International Journal of Pharmaceutics 1992; 88: 53–62
- O'Neal MJ, Heckelman PE, Koch CB, Romann KJ. The Merck Index 14th. Whitehouse Station, NJ 2006; 865
- Trotta M, Cavalli R, Carlotti ME, Battaglia L, Debernardi F. Solid lipid micro-particles carrying insulin formed by solvent-in-water emulsion-diffusion technique. International Journal of Pharmaceutics 2005; 288: 281–288
- Trotta M, Debernardi F, Caputo O. Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique. International Journal of Pharmaceutics 2003; 257: 153–160
- Westesen K, Siekmann B. Biodegradable colloidal drug carrier systems based on solid lipids. Microencapsulation—Methods and industrial applications, S Benita. Marcel Dekker Ltd, Taylor & Francis group, New York 1996; 213–258
- Xiu Y, Xu K. Yaowu Fenxi Zazhi 2001; 21: 191–193